✦ LIBER ✦

An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

✍ Scribed by Maison-Blanche, Pierre; Dakhil, Shaker; Baron, Ari; Rottey, Sylvie; Millard, Fred; Daugaard, Gedske; Machiels, Jean-Pascal; Conkright, William; Sharma, Sunil; Soetekouw, Patricia M. M. B.; Yachnin, Jeffrey; Sengeløv, Lisa; Van Veldhuizen, Peter; Agarwala, Sanjiv S.; Sémiond, Dorothée; Chadjaa, Mustapha; Shen, Liji; Wade, James L.

Book ID: 125344304
Publisher: Springer
Year: 2014
Tongue: English
Weight: 448 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2460-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label study to describe pharmaco

An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function

✍ Cindy L. O’Bryant; Paul Haluska; Lee Rosen; Ramesh K. Ramanathan; Balaji Venugop 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 364 KB

A phase 1 open-label, sequential dose-es

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

✍ Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C.; Shapiro, Geoffrey I.; Kwak, Eun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 318 KB

An open-label, phase 1 study evaluating

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors

✍ Asahina, Hajime; Tamura, Yosuke; Nokihara, Hiroshi; Yamamoto, Noboru; Seki, Yosh 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 368 KB

365 A Phase 1b Open-label, Dose-escalati

365 A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors

✍ Lolkema, M.; Leong, S.; Voest, E.; Freas, E.; Shankar, G.; Brachmann, R.K.; Moss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

An Open-Label Clinical Trial Evaluating

An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors

✍ Joe J. Stephenson; Charles Gregory; Howard Burris; Tim Larson; Udit Verma; Allen 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 134 KB

Safety and efficacy of sunitinib in pati

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

✍ Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB